A
ATARA BIOTHERAPEUTICS INC
NASDAQ: ATRA (Atara Biotherapeutics, Inc.)
Kemas kini terakhir: 2 jam lalu9.38
-0.51 (-5.16%)
| Penutupan Terdahulu | 9.89 |
| Jumlah Dagangan | 16,034 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.70 |
| Harga / Jualan (P/S) | 21.52 |
| Julat 52 Minggu |
| Margin Keuntungan | -7.83% |
| Margin Operasi (TTM) | 49.53% |
| EPS Cair (TTM) | -2.26 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 258.80% |
| Nisbah Semasa (MRQ) | 0.570 |
| Aliran Tunai Operasi (OCF TTM) | -67.24 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -62.49 M |
| Pulangan Atas Aset (ROA TTM) | -1.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Atara Biotherapeutics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
1.6
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.61 |
|
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 22.44% |
| % Dimiliki oleh Institusi | 51.06% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ecor1 Capital, Llc | 30 Jun 2026 | 1,552,000 |
| Redmile Group, Llc | 30 Jun 2026 | 441,701 |
| Mackenzie Financial Corp | 30 Jun 2026 | 233,249 |
| Staley Capital Advisers Inc | 30 Jun 2026 | 50,000 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CHERRY BRIAN N | 9.76 | - | 104,166 | 1,016,660 |
| Jumlah Keseluruhan Kuantiti Bersih | 104,166 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,016,660 | |||
| Purata Pembelian Keseluruhan ($) | 9.76 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CHERRY BRIAN N | Pengarah | 04 Sep 2026 | Beli (+) | 104,166 | 9.76 | 1,016,660 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |